I Walter-Sack
Overview
Explore the profile of I Walter-Sack including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
65
Citations
283
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Seidling H, Schmitt S, Bruckner T, Kaltschmidt J, Pruszydlo M, Senger C, et al.
Qual Saf Health Care
. 2010 Apr;
19(5):e15.
PMID: 20427312
Objectives: Prescription of excessive doses is the most common prescription error, provoking dose-dependent adverse drug reactions. Clinical decision support systems (CDSS) can prevent prescription errors especially when mainly clinically relevant...
2.
Hafner V, Rutsch C, Ding R, Heinrich T, Diedrichs L, Schmidt-Gayk H, et al.
Int J Clin Pharmacol Ther
. 2008 Apr;
46(3):131-5.
PMID: 18397683
Objective: Secondary hyperparathyroidism in hemodialysis patients requires optimal correction of vitamin D deficiency with active vitamin D and analogues. It has been postulated that new vitamin D analogues, i.e. paricalcitol,...
3.
Steiner T, Walter-Sack I, Taupitz J, Hacke W, Strowitzki T
Dtsch Med Wochenschr
. 2008 Apr;
133(15):787-92.
PMID: 18382954
Clinical trials in patients who cannot sign an informed consent are only possible under certain circumstances. The present paper explains the legal prerequisites and ethic rationales, which may allow including...
4.
Rengelshausen J, Goggelmann C, Burhenne J, Riedel K, Mikus G, Walter-Sack I, et al.
Int J Clin Pharmacol Ther
. 2007 Aug;
45(8):431-7.
PMID: 17725176
Objective: Urinary caffeine metabolic ratios used to quantify the activity of numerous drug-metabolizing enzymes are an established component of cocktail approaches for metabolic phenotyping. Because in vitro evidence suggests that...
5.
Bertsche T, Haas M, Oberwittler H, Haefeli W, Walter-Sack I
Dtsch Med Wochenschr
. 2006 May;
131(18):1016-22.
PMID: 16673226
Background And Objective: In selecting drugs for treatment during pregnancy and breastfeeding it is essential to be certain of their safety. But categories are lacking that systematically relate the current...
6.
Walter-Sack I, Haefeli W
Dtsch Med Wochenschr
. 2002 Mar;
127(12):627-33.
PMID: 11907867
No abstract available.
7.
Schwaninger M, Ringleb P, Annecke A, Winter R, Kohl B, Werle E, et al.
J Neurol
. 2000 Nov;
247(9):687-90.
PMID: 11081807
Lipoprotein(a) [Lp(a)] has been identified as an independent risk factor for vascular diseases. There are no data on Lp(a) levels in patients on long-term medication with carbamazepine, phenytoin, phenobarbital, or...
8.
Walter-Sack I, Haefeli W
Ther Umsch
. 2000 Oct;
57(9):557-62.
PMID: 11036435
The rate and extent of drug absorption from the small intestine are related to the release of the active ingredient from a dosage form, its solubility in the liquid phase...
9.
Schwarz S, Knauth M, Schwab S, Walter-Sack I, Bonmann E, Storch-Hagenlocher B
J Neurol Neurosurg Psychiatry
. 2000 Sep;
69(4):516-8.
PMID: 10990514
Two patients with acute disseminated encephalomyelitis after repeated injection of extracts from several different plants are described. There was no evidence of prior infection or vaccination. Both patients recovered rapidly...
10.
Salbach P, Bruckmann M, Turovets O, Kreuzer J, Kubler W, Walter-Sack I
Br J Clin Pharmacol
. 2000 Sep;
50(3):221-6.
PMID: 10971306
Aims: The aim of this investigation was to compare the effects of standard (S) with low molecular weight (LMW) heparin on circulating levels of heparin-binding growth factors (HBGF), known to...